Info

ACEA Biosciences has pioneered the development of high-performance microelectronic systems for cell-based assays. ACEA has developed and is marketing on a world-wide basis its microplate-based biosensor platform for a variety of applications in drug development, toxicology, cancer research, and medical microbiology and virology. ACEA's products are designed to meet the increasing needs of the life science research and drug discovery markets by providing cost-effective, automated, high content, real time detection systems that simplify complex cell-based assay procedures and increase productivity. ACEA's current product portfolio includes the RT-CES® microplate biosensor platform featuring 16 well and 96 well plates and individual workstations. In addition, a 6 X 96 multi-plate® station is now available to increase the assay throughput. Using the same microelectronic sensor technology, the revolutionary RT-CIMÔ System allows researchers to study the invasiveness of cancer cells in a highly quantitative, microplate- based, label-free, cost effective assay. With its international reach, ACEA Biosciences works closely with scientists throughout the world. Hangzhou, China is the site of ACEA's world-class manufacturing operations. A network of distributors assures the timely sales, service, and support of ACEA's growing product line throughout the world. ACEA Biosciences headquarter is in San Diego, California.